PBRM1, another component of the SWI/SNF complex, is found mutated in 41% of renal clear cell carcinomas, and sunitinib, a common clinical kidney cancer treatment, has no significant effect on PBRM1‐mutated renal clear cell carcinomas, but it is sensitive to anti‐VEGF drugs.71, 72. Here, VEGFA is linked to clear cell renal carcinoma.